CCI-779 in Treating Patients With Metastatic Melanoma
Status:
Completed
Trial end date:
2005-09-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of CCI-779 in treating patients who have
metastatic melanoma.